GLAXOSMITHKLINE PLC 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-20 4:12 pm Sale |
2022-09-16 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 0 0.000% |
-9,644,807 (Position Closed) |
Filing |
| 2022-08-03 08:33 am Unchanged |
2022-08-03 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 12.700% |
0 (Unchanged) |
Filing |
| 2022-02-10 4:48 pm Unchanged |
2021-11-08 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 13.100% |
0 (Unchanged) |
Filing |
| 2020-06-22 5:13 pm Unchanged |
2020-06-22 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 15.300% |
0 (Unchanged) |
Filing |
| 2020-06-17 4:07 pm Sale |
2020-06-17 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 15.300% |
-1 (-0.00%) |
Filing |